A few comments on the background of the article "Off label - practical consequences of unclear legislation" Cover Image

Kilka uwag na kanwie artykułu pt. „Off-label – praktyczne konsekwencje niejasnego prawa”
A few comments on the background of the article "Off label - practical consequences of unclear legislation"

Author(s): Rafał Kubiak
Subject(s): Review, Health and medicine and law
Published by: Instytut Filozofii Uniwersytetu Jagiellońskiego
Keywords: medical experiment; Characteristics of Medicinal Product; off-label treatment; patient consent; criminal liability

Summary/Abstract: Polish medical law does not explicitly regulate the possibility of off-label use of medicines. Such procedures therefore raise doubts in medical practice, where medicines are often prescribed beyond the Characteristic of Medicinal Product. This phenomenon particularly affects the treatment of children, as there is a lack of registered medicines in this age group, but they are registered for use in adults. Since such treatment goes beyond the scope of registration, a dilemma arises as to whether it is permissible and, if so, under what conditions and whether sanctions are imposed on the medical professional using the off-label medicine. These issues are addressed in an article by Dr Maria Gutowska-Ibbs, entitled 'Off label - practical consequences of unclear legislation". The present study complements these considerations and is in part an ad vocem statement. The article attempts to differentiate between the use of off-label medicines and medical experiments, following the criterion of the purpose for which a given medical action is performed. The limits of admissibility of such actions under criminal law are also discussed in more detail. Off-label treatment is considered through the prism of the required precautionary rules, compliance with which is the antithesis of inadvertence. It is assumed that if the drug was administered in accordance with current medical knowledge and the treatment is adequate to the patient's condition, there is no violation of these rules, which excludes the imputation of inadvertence. An extensive section of the study is devoted to the issue of the patient's consent to treatment outside the indications. Above all, it emphasises the need to explain in detail to the patient the circumstances of prescribing such a drug and, on this basis, to obtain informed consent. It also stresses the importance of the written form of consent, which can have a significant evidentiary impact in potential litigation.

  • Issue Year: 21/2024
  • Issue No: 81
  • Page Range: 33-51
  • Page Count: 19
  • Language: Polish
Toggle Accessibility Mode